Shares of Bionano Genomics slid by a staggering 32.05% in 30 days from $8.82 to $5.99 at 20:26 EST on Monday, after four successive sessions in a row of losses. NASDAQ Composite is sliding 0.48% to $13,895.12, after two sequential sessions in a row of losses.
Bionano Genomics’s last close was $6.37, 161.94% under its 52-week high of $15.69.
Bionano Genomics’s Sales
Bionano Genomics’s sales growth is 154.4% for the current quarter and 203.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 86.7% and 44.4%, respectively.
Bionano Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 43%, now sitting on 8.5M for the twelve trailing months.
Bionano Genomics’s Stock Yearly Top and Bottom Value
Bionano Genomics’s stock is valued at $5.99 at 20:26 EST, way under its 52-week high of $15.69 and way higher than its 52-week low of $0.28.
Bionano Genomics’s Moving Average
Bionano Genomics’s value is way under its 50-day moving average of $9.47 and way above its 200-day moving average of $4.64.
More news about Bionano Genomics.